AstraZeneca (NYSE: AZN) reported Q1 EPS of $1.81, $0.03 better than the analyst estimate of $1.78. Revenue for the quarter came in at $7.35 billion versus the consensus estimate of $7.85 billion.

For earnings history and earnings-related data on AstraZeneca (AZN) click here.

Earnings